This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fossa SD et al. (1999) Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 80: 1392–1399
De Giorgi U et al. (2002) The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients. Haematologica 87: 95–104
International Germ Cell Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594–603
Motzer RJ et al. (2007) Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25: 247–256
Pico JL et al. (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16: 1152–1159
Acknowledgements
The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice. The authors are members and wrote this article on behalf of the Italian Germ Cell Cancer Group (IGG) and Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rosti, G., De Giorgi, U. & Pedrazzoli, P. Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?. Nat Rev Clin Oncol 5, 126–127 (2008). https://doi.org/10.1038/ncponc1018
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1018